Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/16/2022* -- Results Q2 2022 -- -0.12 --
11/15/2021 -- Results Q3 2021 -- -- --
08/16/2021 -- Results Q2 2021 -- -- --
05/21/2021 -- Results Q1 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/16/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/15/2021
Beat/Miss Upgrade
Return Since -57.31%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
URL https://www.bonebiologics.com
Investor Relations URL N/A
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style N/A
Next Earnings Release Aug. 16, 2022 (est.)
Last Earnings Release Nov. 15, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio --
Cash Payout Ratio --
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
--
--
-81.23%
-53.80%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-17.31%
--
-27.18%
-17.04%
-49.64%
3.57K%
-21.18%
-53.63%
-35.26%
--
--
--
--
--
-10.67%
-69.63%
-73.35%
--
--
--
--
--
--
--
-65.11%
--
--
--
--
--
--
--
-83.89%
As of June 24, 2022.

Profile

Edit
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
URL https://www.bonebiologics.com
Investor Relations URL N/A
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style N/A
Next Earnings Release Aug. 16, 2022 (est.)
Last Earnings Release Nov. 15, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter BBLG Tweets